SDS23 antibody is a specialized reagent targeting the Sds23 protein in Schizosaccharomyces pombe (fission yeast). Sds23 is a regulatory protein involved in cell cycle progression, particularly during mitosis and cytokinesis . This antibody serves as a critical tool for studying PP2A (protein phosphatase 2A) family regulation and its impact on cell division symmetry .
The SDS23 antibody is a polyclonal rabbit serum developed against recombinant Sds23 protein (amino acids 98–345) . Key characteristics include:
| Property | Details |
|---|---|
| Target Species | Schizosaccharomyces pombe (fission yeast) |
| Immunogen | Recombinant Sds23 protein (residues 98–345) |
| Applications | Western blotting (~1:500 dilution) |
| Reactivity | Specific to Sds23 in S. pombe |
| Storage | 4°C (short term); -20°C (long term) |
| Buffer | 0.05% sodium azide |
This antibody enables detection of Sds23’s role in PP1 (protein phosphatase 1) and 20S cyclosome/APC regulation during anaphase progression .
Mechanism: Sds23 inhibits PP2A phosphatases, ensuring proper spatial control of cytokinesis. Loss of Sds23 (sds23∆) leads to asymmetric cell division due to mislocalized contractile actomyosin rings (CARs) .
Key Observations:
Synergy with Igo1: Deletion of sds23 exacerbates defects in igo1∆ mutants (lacking the PP2A inhibitor Igo1), highlighting overlapping roles in PP2A regulation .
Cell Cycle Analysis: Used to investigate Sds23’s role in mitotic progression and cytokinesis .
Protein Localization: Validates Sds23 expression and interactions in fission yeast via Western blotting .
KEGG: ago:AGOS_AAR154W
STRING: 33169.AAS50521
SDS23 is a protein in Schizosaccharomyces pombe (fission yeast) that functions to facilitate progression in anaphase during mitotic cell cycle. It plays a critical role in the regulation of cell division, particularly in anaphase progression and cytokinesis. For initiating anaphase in fission yeast, protein phosphatase 1 (PP1) and 20S cyclosome/APC are required. The sds23 gene acts as a multicopy suppressor for mutations in PP1 and the 20S cyclosome/APC, suggesting that increased gene dosage can reduce the requirement for these proteins in anaphase initiation .
While sds23 is not essential for cell viability, deletion mutants show retarded progression of anaphase and cytokinesis, along with aberrant cell shape. This indicates SDS23's involvement not only in anaphase progression but also in cytokinesis and cell shape control. Interestingly, SDS23 is neither physically bound to PP1 nor a component of the cyclosome, suggesting it regulates these factors through alternative mechanisms .
Immunofluorescence microscopy to study subcellular localization
Immunoprecipitation to investigate protein interactions
ChIP (Chromatin Immunoprecipitation) if SDS23 has DNA-associated functions
For each application beyond Western blotting, careful optimization is required as these have not been extensively validated according to available documentation. When planning experimental approaches, consider following similar optimization protocols as used for other yeast proteins, taking into account the specific characteristics of SDS23.
For short-term storage, anti-SDS23 antibody can be stored at 4°C. For long-term storage, maintain at -20°C, being sure to aliquot the antibody to avoid repeated freeze-thaw cycles that can degrade antibody quality . When working with the antibody:
Prepare small aliquots (10-20 μl) upon receipt to minimize freeze-thaw cycles
Thaw aliquots on ice or at 4°C rather than room temperature
Centrifuge briefly after thawing to collect contents at the bottom of the tube
Add carrier protein (BSA, 0.1-1%) if further diluting for storage
Include 0.05% sodium azide as a preservative for diluted antibody solutions
Proper storage and handling protocols are essential for maintaining antibody sensitivity and specificity, especially for applications requiring high antibody performance.
When using anti-SDS23 antibodies, incorporate these essential controls:
Positive Controls:
Wild-type S. pombe lysate (showing the expected 46 kDa band for SDS23)
Overexpression samples (cells transformed with SDS23 on a multicopy plasmid)
Negative Controls:
sds23 deletion mutant lysate (should show absence of the specific band)
Secondary antibody-only control (to identify non-specific binding of secondary antibody)
Pre-immune serum control (if available, to establish baseline reactivity)
Additional Validation Controls:
Peptide competition/blocking experiment (pre-incubating antibody with the immunizing peptide should abolish specific signal)
Gradient dilution series to establish detection limits and optimal concentration
Including these controls will help validate antibody specificity and optimize experimental conditions, particularly important when investigating SDS23's role in complex processes like anaphase progression.
Optimizing immunofluorescence for SDS23 detection in S. pombe requires addressing the unique challenges of yeast cell wall and fixation:
Cell Wall Digestion:
Use enzymatic treatment (zymolyase or lysing enzymes) to create spheroplasts
Carefully optimize digestion time (typically 10-30 minutes) to balance accessibility without compromising cellular structures
Fixation Protocol:
Compare formaldehyde (3-4%) and methanol fixation methods
For anaphase studies, formaldehyde often better preserves spindle structures
Include 0.1-0.2% glutaraldehyde for improved structural preservation
Permeabilization:
Use 0.1% Triton X-100 or 0.5% NP-40 after fixation
For challenging epitopes, test methanol/acetone treatment (-20°C, 5 minutes)
Blocking and Antibody Dilutions:
Block with 1-5% BSA or normal serum from secondary antibody host species
Test a range of primary antibody dilutions (1:100 to 1:1000)
Include 0.1% Tween-20 in all buffers to reduce background
Co-staining:
Include tubulin staining to visualize spindles and determine cell cycle stage
DAPI counterstaining for nuclear positioning
For cell cycle studies, synchronize cultures or use asynchronous populations with morphological markers to identify cells at different mitotic stages when analyzing SDS23 localization during anaphase.
Though SDS23 is not physically bound to PP1 or the cyclosome , investigating its functional relationships with these complexes requires sophisticated approaches:
Proximity Ligation Assay (PLA):
Use anti-SDS23 antibody alongside antibodies against PP1 or cyclosome components
PLA can detect proteins in close proximity (≤40 nm) even without direct binding
Compare signal distribution in wild-type versus genetically modified strains
Co-immunoprecipitation with Crosslinking:
Use membrane-permeable crosslinkers (DSP or formaldehyde) to capture transient interactions
Perform reciprocal IPs with antibodies against SDS23, PP1, and cyclosome components
Analyze eluates using mass spectrometry to identify interaction networks
Functional Reconstitution:
Purify recombinant SDS23 using antibody-based affinity columns
Set up in vitro assays measuring PP1 and cyclosome/APC activity
Assess how adding purified SDS23 affects enzyme kinetics
These approaches can help elucidate how SDS23 regulates PP1 and cyclosome/APC activity without direct binding, potentially revealing novel regulatory mechanisms in anaphase progression.
Investigating post-translational modifications (PTMs) of SDS23 requires specialized techniques:
Phosphorylation Analysis:
Use phospho-specific antibodies if available, or develop new ones for suspected sites
Combine with phosphatase treatment controls to validate phospho-specific signals
Employ Phos-tag™ gels to resolve phosphorylated from non-phosphorylated SDS23
PTM Mapping Workflow:
Immunoprecipitate SDS23 from synchronized cultures at different cell cycle stages
Analyze by mass spectrometry to identify PTMs (phosphorylation, ubiquitination, etc.)
Validate findings using site-specific mutants (e.g., phospho-null or phospho-mimetic)
Comparison Table of PTM Detection Methods:
| Method | Advantages | Limitations | Sample Requirements |
|---|---|---|---|
| Western blot with PTM-specific antibodies | Fast, specific for known sites | Limited to known/available antibodies | 10-50 μg total protein |
| Phos-tag™ SDS-PAGE | Resolves all phospho-forms | Cannot identify specific sites | 10-30 μg total protein |
| IP-Mass Spectrometry | Comprehensive, identifies sites | Expensive, requires specialized equipment | 1-5 mg total protein |
| 2D gel electrophoresis | Resolves multiple PTM forms | Labor-intensive, low throughput | 100-500 μg total protein |
Understanding PTMs of SDS23 may reveal regulatory mechanisms controlling its function during specific cell cycle phases.
When antibody-based observations conflict with genetic data regarding SDS23 function, consider these reconciliation approaches:
Epitope Accessibility Analysis:
Context-Dependent Activity:
SDS23 may have different functions depending on subcellular localization
Perform fractionation experiments to separate cytoplasmic from nuclear pools
Compare subcellular distribution in wild-type versus genetic mutant backgrounds
Compensatory Mechanisms in Genetic Models:
Genetic knockouts may trigger compensatory mechanisms absent in acute antibody inhibition
Compare acute inhibition (if possible) with genetic deletion
Look for upregulation of functionally related proteins in deletion mutants
Experimental Validation Matrix:
| Observation Type | Validation Approach | Expected Outcome if Real | Expected Outcome if Artifact |
|---|---|---|---|
| Antibody localization contradicts genetic data | Test specificity in deletion strain | No signal in deletion background | Persistent signal in deletion (indicates non-specificity) |
| Unexpected protein interactions | Perform reverse IP and crosslinking studies | Consistent detection of interaction | Inconsistent or buffer-dependent results |
| Discrepancy between phenotypes | Complementation with tagged constructs | Rescue with wild-type but not mutant | No rescue or non-specific effects |
Systematic investigation of contradictions often leads to novel insights about protein function in different contexts or conditions.
To investigate SDS23's anaphase-specific functions, combine antibody techniques with cell synchronization:
Synchronization Methods for S. pombe:
Temperature-sensitive cdc mutants:
Use cdc25-22 for G2 arrest or nda3-KM311 for metaphase arrest
Release from arrest and collect timepoints through anaphase
Centrifugal Elutriation:
Separate cells by size/density to obtain populations at specific cell cycle stages
Does not require genetic modification or drug treatments
Analytical Approaches:
Immunofluorescence Timecourse:
Fix cells at 2-5 minute intervals after synchronous release
Co-stain for SDS23, tubulin (spindles), and DNA
Quantify SDS23 signal intensity and localization changes
Chromatin Association Analysis:
Perform chromatin fractionation at defined timepoints
Western blot fractions for SDS23 to detect potential chromatin association during anaphase
Compare with known chromatin and soluble markers
Proximity-Based Interaction Mapping:
Employ BioID or APEX2 proximity labeling with SDS23 as the bait
Analyze timepoints through anaphase progression
Identify dynamic interaction partners specific to anaphase
These approaches will help delineate how SDS23 contributes to anaphase progression, potentially revealing stage-specific interactions and regulatory mechanisms.
To investigate cell cycle-dependent regulation of SDS23, implement these approaches:
Phosphorylation Profiling Across Cell Cycle:
Synchronize cells and collect samples at defined cell cycle points
Immunoprecipitate SDS23 using anti-SDS23 antibodies
Analyze by:
Phospho-specific Western blotting
Mass spectrometry to identify modification sites
Phos-tag gel analysis to resolve different phospho-forms
Quantitative Analysis of Modification Dynamics:
Use SILAC or TMT labeling for quantitative proteomics
Compare modification stoichiometry across cell cycle stages
Correlate modifications with functional events in anaphase
Functional Validation of Modification Sites:
Generate phospho-mutant variants (alanine substitutions)
Assess rescue of sds23Δ phenotypes
Analyze cell cycle progression and anaphase timing in mutants
Example Experimental Design for Cell Cycle Modification Analysis:
| Time Point | Cell Cycle Stage | Expected SDS23 Status | Analysis Method |
|---|---|---|---|
| 0 min | G2 arrest | Baseline phosphorylation | IP-MS, Western blot |
| 15 min | Early mitosis | Potential phosphorylation increase | IP-MS, Western blot |
| 30 min | Metaphase/Anaphase transition | Peak modification state | IP-MS, Western blot |
| 45 min | Late anaphase | Beginning of dephosphorylation | IP-MS, Western blot |
| 60 min | Cytokinesis | Return to baseline or different pattern | IP-MS, Western blot |
This comprehensive approach can reveal how post-translational modifications regulate SDS23 function throughout the cell cycle, particularly during the critical anaphase transition.
Although SDS23 is not primarily known as a DNA-binding protein, investigating potential chromatin associations requires specialized ChIP protocols:
Crosslinking Optimization:
Test both formaldehyde (1%) and dual crosslinkers (formaldehyde plus disuccinimidyl glutarate)
Optimize crosslinking time (typically 5-15 minutes) for yeast cells
Include glycine quenching (125 mM final concentration)
Chromatin Fragmentation:
For S. pombe, use both enzymatic (MNase) and sonication approaches
Target fragment sizes of 200-500 bp for high resolution
Verify fragmentation by agarose gel electrophoresis
Immunoprecipitation Conditions:
Pre-clear chromatin with protein A/G beads to reduce background
Use 2-5 μg anti-SDS23 antibody per ChIP reaction
Include negative control antibody (normal rabbit IgG)
Include positive control antibody against known chromatin factors
Washing and Elution:
Use stringent wash buffers (increasing salt concentration)
Elute with SDS buffer at 65°C
Reverse crosslinks (65°C overnight or 6 hours)
Analysis Methods:
qPCR for candidate regions (e.g., centromeres, replication origins)
ChIP-seq for genome-wide distribution
Compare profiles during different cell cycle stages
This protocol adaptation allows investigation of whether SDS23 associates with specific chromatin regions during anaphase progression, potentially revealing direct interactions with DNA or chromatin-associated factors.
Developing quantitative assays for SDS23 requires careful consideration of several factors:
Quantitative Western Blot Approach:
Use recombinant SDS23 protein to generate a standard curve
Include internal loading controls (housekeeping proteins)
Employ fluorescent secondary antibodies for wider linear range
Use digital imaging systems rather than film for quantification
ELISA Development Considerations:
Determine optimal coating conditions (direct vs. sandwich format)
Evaluate different capture and detection antibody combinations
Establish standard curves with recombinant protein
Validate assay parameters (sensitivity, specificity, precision)
Activity Assay Development:
If SDS23 regulates PP1 or cyclosome/APC indirectly, consider:
Measuring PP1 phosphatase activity in the presence/absence of immunopurified SDS23
Assessing cyclosome/APC-mediated protein degradation rates with varying SDS23 levels
Developing reporter systems responsive to these activities in cells
Assay Validation Parameters Table:
| Parameter | Acceptance Criteria | Validation Method |
|---|---|---|
| Specificity | No signal in sds23Δ samples | Negative control testing |
| Linearity | R² > 0.98 over working range | Standard curve analysis |
| Precision | CV < 15% intra-assay, < 20% inter-assay | Replicate testing |
| Accuracy | 80-120% recovery of spiked samples | Spike-recovery experiments |
| Sensitivity | LLOQ sufficient to detect endogenous levels | Serial dilution analysis |
Developing well-validated quantitative assays will enable more precise studies of SDS23 regulation and function across experimental conditions and genetic backgrounds.